Multiparametric Approach to Identify a CMR-based Tricuspid Regurgitation Classification

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

76 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-02-16

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aims of this study are:

1. to explore a novel 2D-Cardiovascular magnetic resonance (CMR) indirect method for tricuspid regurgitation (TR) quantification (ATRIAL method) relying on right atrium variables, and assess its agreement with the traditional indirect method (involving right ventricle variables) and the direct method (based on through-plane phase contrast (PC) sequences on the tricuspid valve);
2. to assess the agreement of TR volume (RVol) and regurgitant fraction quantification from 2D-CMR methods with transthoracic echocardiography and 4DF-CMR methods;
3. to assess the diagnostic performance of 2D-CMR in classifying TR, in terms of RVol and regurgitant fraction, with respect to echocardiographic transthoracic echocardiography grades.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intraventricular Stasis in Non Ischemic Dilated Myocardiopathy

NCT03415789

Dilated Cardiomyopathy Thrombosis Stroke

COMPLETED

Comparison of Data Obtained by Echocardiography and Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy

NCT00315783

Hypertrophic Cardiomyopathy

UNKNOWN

Cardiac Magnetic Resonance for Diagnosis, Treatment Guidance and Prognosis of Cardiac Masses (CMR)

NCT07335770

Cardiac Masses

ENROLLING_BY_INVITATION

Quantification of Mitral Regurgitation Using 4D MRI Flow : Comparison With 2D MRI Flow and Echocardiography Using the Evolution of Left Ventricular Remodeling as a Reference

NCT07066904

Mitral Regurgitation (MR)

NOT_YET_RECRUITING NA

Prognotic Role of CMR in Takotsubo Syndrome

NCT06277297

Takotsubo Cardiomyopathy Machine Learning Magnetic Resonance Imaging

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tricuspid Regurgitation Congenital

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients aged ≥ 18 years with the diagnosis of al least mild-degree tricuspid regurgitation, who:
* patients that are scheduled for a Cardiovascular Magnetic Resonance examination in our Institution

Exclusion Criteria

* Patients with previous surgical or transcatheter interventions on the tricuspid valve
* Patients with Ebstein's disease
* Subjects with pace-maker or intracardiac defibrillator
* Subjects with intrabody ferromagnetic material precluding patient's safety
* Patients with claustrophobia or breath-holding precluding an adequate CMR images quality
* Pregnant women

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No